Loading data for SNYNF — first visit, this takes a few seconds.
Sanofi (SNYNF)
OTC Markets OTCPK: SNYNF
· Real-Time Price · USD
84.02
-3.30 (-3.78%)
At close: Sep 11, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Sanofi (SNYNF) Stock Price, Analysis & Data
No data available
| Bid | 82.81 |
| Market Cap | 101B |
| Revenue (ttm) | 48.9B |
| Net Income (ttm) | 3.94B |
| 0.28 | |
| 3.77 | |
| 22.29 | |
| 9.08 | |
| P/B (ttm) | 1.25 |
| P/S (ttm) | 2.06 |
| Earnings Date | Oct 30, 2026 |
| Ask | 87.54 |
| Volume | 311 |
| Avg. Volume (20D) | 33,601 |
| Open | 92.65 |
| Previous Close | 87.32 |
| Day's Range | 89.80 - 92.65 |
| 52-Week Range | 80.74 - 106.34 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $4.84 (5.76%) |
| Ex-Dividend Date | May 5, 2026 |
About SNYNF
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a ...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Apr 9, 2008
Employees 74,846
Stock Exchange OTC Markets OTCPK
Ticker Symbol SNYNF
Website https://www.sanofi.com
Financial Performance
In 2025, Sanofi's revenue was 46.72B, an increase of 5.49% compared to the previous year's 44.29B. Earnings were 7.81B, an increase of 40.52%.
Financial StatementsEarnings Surprise
Sanofi has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
Sanofi is scheduled to release its earnings on Oct 30, 2026, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2